A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria

Chest

Volumn 150, Issue 5, 2016, Pages 1080-1090

  Dilektasli, Asli Gorek ^a,b   Porszasz, Janos ^a   Casaburi, Richard ^a   Stringer, William W ^a   Bhatt, Surya P ^c   Pak, Youngju ^a   Rossiter, Harry B ^a,d   Washko, George ^e   Castaldi, Peter J ^e   Estepar, Raul San Jose ^e   Hansen, James E ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b ULUDAG UNIVERSITY   (Turkey)

^c and Clinical Center   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

airway obstruction; COPD; spirometry; thoracic radiology

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; BODY MASS; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; EMPHYSEMA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED EXPIRATORY VOLUME IN SIX SECOND; FORCED EXPIRATORY VOLUME IN THREE SECOND; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL DYSPNEA SCORE; MIDDLE AGED; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; RESPIRATORY TRACT PARAMETERS; SIX MINUTE WALK TEST; SMOKING; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THORAX RADIOGRAPHY; CLASSIFICATION; DIAGNOSTIC IMAGING; DISABILITY; PATHOPHYSIOLOGY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84994453368     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.06.047     Document Type: Conference Paper

References (59)

1. 3/FVC to improve detection of airway obstruction. J COPD F 2:2 (2015), 94–102.
2. 2 Swanney, M.P., Ruppel, G., Enright, P.L., et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 63:12 (2008), 1046–1051.
3. 3 Vollmer, W.M., Gislason, T., Burney, P., et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 34:3 (2009), 588–597.
4. 4 Vestbo, J., Hurd, S.S., Agusti, A.G., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:4 (2013), 347–365.
5. 5 Pellegrino, R., Viegi, G., Brusasco, V., et al. Interpretative strategies for lung function tests. Eur Respir J 26:5 (2005), 948–968.
6. 6 Hankinson, J.L., Odencrantz, J.R., Fedan, K.B., Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:1 (1999), 179–187.
7. 7 Quanjer, P.H., Stanojevic, S., Cole, T.J., et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40:6 (2012), 1324–1343.
8. 8 Hogg, J.C., Macklem, P.T., Thurlbeck, W., Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278:25 (1968), 1355–1360.
9. 9 Cosio, M., Ghezzo, H., Hogg, J., et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:23 (1978), 1277–1281.
10. 10 McNulty, W., Usmani, O.S., Techniques of assessing small airways dysfunction. Eur Clin Respir J, 1, 2014 http://www.ecrj.net/index.php/ecrj/article/view/25898 Accessed July 22, 2016.
11. 11 Basic spirometry. Hansen, J.E., (eds.) Pulmonary Function Testing & Interpretation, 2011, Jaypee Brothers Medical Publishers, London, England, 42–87.
12. 12 Hansen, J.E., Sun, X.G., Wasserman, K., Discriminating measures and normal values for expiratory obstruction. Chest 129:2 (2006), 369–377.
13. 13 Hansen, J.E., Cigarette smoking and the disadvantages of using a fixed ratio of FEV 1/FVC to diagnose airway obstruction. Turk Thorac J 10:2 (2009), 82–85.
14. 14 Lutchmedial, S.M., Creed, W.G., Moore, A.J., et al. How common is airflow limitation in patients with emphysema on CT scan of the chest?. Chest 148:1 (2015), 176–184.
15. 15 Regan, E.A., Lynch, D.A., Curran-Everett, D., et al., Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 175:9 (2015), 1539–1549.
16. 16 Wan, E.S., Hokanson, J.E., Murphy, J.R., et al. Clinical and radiographic predictors of GOLD: unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 184:1 (2011), 57–63.
17. 17 Rennard, S.I., Drummond, M.B., Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet 385:9979 (2015), 1778–1788.
18. 18 Miller, M.R., Pincock, A.C., Grove, D.M., Patterns of spirogram abnormality in individual smokers. Am Rev Respir Dis 132:5 (1985), 1034–1040.
19. 19 Regan, E.A., Hokanson, J.E., Murphy, J.R., et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7:1 (2010), 32–43.
20. 20 Coxson, H.O., Rogers, R.M., Whittall, K.P., et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 159:3 (1999), 851–856.
21. 21 Lynch, D.A., Austin, J.H., Hogg, J.C., et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology 277:1 (2015), 192–205.
22. 22 Gevenois, P.A., De Vuyst, P., De Maertelaer, V., et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 154:1 (1996), 187–192.
23. 23 Schroeder, J.D., McKenzie, A.S., Zach, J.A., et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol 201:3 (2013), 460–470.
24. 24 Matsuoka, S., Kurihara, Y., Yagihashi, K., et al. Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. AJR Am J Roentgenol 190:3 (2008), 762–769.
25. 25 Jones, P.W., Quirk, F.H., Baveystock, C.M., The St George's Respiratory Questionnaire. Respir Med 85:suppl B (1991), 25–31.
26. 26 Bestall, J.C., Paul, E.A., Garrod, R., et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:7 (1999), 581–586.
27. 27 Celli, B.R., Cote, C.G., Marin, J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:10 (2004), 1005–1012.
28. 28 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:1 (2002), 111–117.
29. 29 Miller, M.R., Hankinson, J., Brusasco, V., et al. Standardisation of spirometry. Eur Respir J 26:2 (2005), 319–338.
30. 30 Hankinson, J.L., Crapo, R.O., Jensen, R.L., Spirometric reference values for the 6-s FVC maneuver. Chest 124:5 (2003), 1805–1811.
31. 31 The definition of emphysema: Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 132:1 (1985), 182–185.
32. 32 Hasegawa, M., Nasuhara, Y., Onodera, Y., et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:12 (2006), 1309–1315.
33. 33 Zach, J.A., Newell, J.D. Jr., Schroeder, J., et al., COPDGene Investigators. Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol 47:10 (2012), 596–602.
34. 34 Hersh, C.P., Washko, G.R., Estepar, R.S.J., et al., COPDGene Investigators. Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res, 14, 2013, 42.
35. 35 Jones, P.W., Tabberer, M., Chen, W.H., Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med, 11, 2011, 42.
36. 36 Casaburi, R., Dilektasli, A.G., Porszasz, J., et al., Genetic Epidemiology of COPD (COPDGene) Investigators. Establishing clinically meaningful cutoffs for %emphysema and %gas trapping in quantitative chest CT scans. [abstract OA2944] Eur Respir J, 46(suppl 59), 2015.
37. 37 Morris, Z.Q., Coz, A., Starosta, D., An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest 144:4 (2013), 1117–1123.
38. 38 Zelter, M., The return of FEV3. Chest 144:4 (2013), 1089–1091.
39. 39 O'Donnell, R.A., Peebles, C., Ward, J.A., et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 59:10 (2004), 837–842.
40. 40 Teel, G.S., Engeler, C.E., Tashijian, J.H., et al. Imaging of small airways disease. Radiographics 16:1 (1996), 27–41.
41. 41 Bommart, S., Marin, G., Bourdin, A., et al. Relationship between CT air trapping criteria and lung function in small airway impairment quantification. BMC Pulm Med, 14, 2014, 29.
42. 42 Mohamed Hoesein, F.A., de Hoop, B., Zanen, P., et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 66:9 (2011), 782–787.
43. 43 Bhatt, S.P., Soler, X., Wang, X., et al., COPDGene Investigators. Association between functional small airways disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 194:2 (2016), 178–184.
44. 44 Verbanck, S., Schuermans, D., Paiva, M., et al. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 174:8 (2006), 853–857.
45. 45 Mead, J., The lung's “quiet zone.”. N Engl J Med 282:23 (1970), 1318–1319.
46. 46 Hogg, J.C., McDonough, J.E., Sanchez, P.G., et al. Micro-computed tomography measurements of peripheral lung pathology in chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:6 (2009), 546–549.
47. 47 McDonough, J.E., Yuan, R., Suzuki, M., et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:17 (2011), 1567–1575.
48. 48 Akpinar-Elci, M., Fedan, K., Enright, P., FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 27:2 (2006), 374–377.
49. 49 Swanney, M.P., Jensen, R.L., Crichton, D.A., et al. FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 162:3 (2000), 917–919.
50. 50 Bhatt, S.P., Kim, Y.I., Wells, J.M., et al. FEV(1)/FEV(6) to diagnose airflow obstruction: comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc 11:3 (2014), 335–341.
51. 51 Demir, T., Ikitimur, H.D., Koc, N., et al. The role of FEV6 in the detection of airway obstruction. Respir Med 99:1 (2005), 103–106.
52. 52 Jing, J.Y., Huang, T.C., Cui, W., et al. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest 135:4 (2009), 991–998.
53. 53 Perez-Padilla, R., Wehrmeister, F.C., Celli, B.R., et al., PLATINO Team. Reliability of FEV 1/FEV 6 to diagnose airflow obstruction compared with FEV 1/FVC: the PLATINO longitudinal study. PLoS One, 8(8), 2013, e67960.
54. 54 Vandevoorde, J., Verbanck, S., Schuermans, D., et al. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 127:5 (2005), 1560–1564.
55. 55 Hyde, D.M., Hamid, Q., Irvin, C.G., Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J Allergy Clin Immunol 124:6 suppl (2009), 72–77.
56. 56 Kim, V., Pechulis, R.M., Abuel-Haija, M., et al. Small airway pathology and bronchoreversibility in advanced emphysema. COPD 7:2 (2010), 93–101.
57. 57 Sterk, P.J., Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J 23:4 (2004), 497–498.
58. 58 Hansen, J.E., Sun, X.G., Wasserman, K., Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?. Eur Respir J 27:6 (2006), 1244–1250.
59. 59 Lam, D.C., Fong, D.Y., Yu, W.C., et al. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese. Int J Tuberc Lung Dis 16:5 (2012), 681–686.